Clinical Trial Update: High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing high-dose vs low-dose methylprednisolone in correction of congenital acynotic heart disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Ain Shams University | Conditions: Anesthesia | Phase 4 | Status: UNKNOWN